Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Avatrombopag is a novel oral, nonpeptide thrombopoietin receptor agonist (TPO-RA). A few studies have shown that avatrombopag is effective against thrombocytopenia. However, no systematic review has been conducted on the efficacy and safety of avatrombopag. Therefore, the aim of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunlu, Li, Xiaoxuan, Huang, Feihong, Yang, Jing, Wu, Anguo, Wang, Long, Qin, Dalian, Zou, Wenjun, Wu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677019/
https://www.ncbi.nlm.nih.gov/pubmed/31402863
http://dx.doi.org/10.3389/fphar.2019.00829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677019/
https://www.ncbi.nlm.nih.gov/pubmed/31402863
http://dx.doi.org/10.3389/fphar.2019.00829

Ejemplares similares